Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice.

MLA

Meng, Huan, et al. “Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice.” ACS Nano, vol. 9, no. 4, 2015, pp. 3540–57. EBSCOhost, https://doi.org/10.1021/acsnano.5b00510.

APA

Meng, H., Wang, M., Liu, H., Liu, X., Situ, A., Wu, B., Ji, Z., Chang, C. H., & Nel, A. E. (2015). Use of a lipid-coated mesoporous silica nanoparticle platform for synergistic gemcitabine and paclitaxel delivery to human pancreatic cancer in mice. ACS Nano, 9(4), 3540–3557. https://doi.org/10.1021/acsnano.5b00510

Chicago

Meng, Huan, Meiying Wang, Huiyu Liu, Xiangsheng Liu, Allen Situ, Bobby Wu, Zhaoxia Ji, Chong Hyun Chang, and Andre E Nel. 2015. “Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice.” ACS Nano 9 (4): 3540–57. doi:10.1021/acsnano.5b00510.